Liming Shao

This inventor holds 38 USPTO granted patents and 6 published patent applications, plus 8 CIPO patents and 8 EPO patents, primarily in Monoamine Reuptake Inhibitors. Top assignees: Sunovion Pharmaceuticals Inc., Sepracor, Inc., Pgi Drug Discovery LLC. Active years: 2002-2022.

USPTO Granted Patents = 38 (Patent Applications = 6)

% Patents Active = 73.7

CIPO Patents = 8 (Patent Applications = 4)

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 4.9

ph-index = 8

Forward Citations = 240(Granted Patents)

Company Filing History:

21 out of 130

Sunovion Pharmaceuticals Inc.

Pgi Drug Discovery LLC

where one patent can have more than one assignee

Years Active: 2002-2022

Loading Chart...

Areas of Expertise:

Monoamine Reuptake Inhibitors

Heteroaryl Compounds

Multicyclic Compounds

Cycloalkylamines

Triple Reuptake Inhibitors

Phenyl Substituted Cycloalkylamines

Pyrrolidine

Ligands for Receptors

Antipsychotic Sulfonamides

Stereoselective Synthesis

Heterocyclic Analgesics

3-Substituted Piperidines

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11332462 - Heteroaryl compounds and methods of use thereof (2022-05-17),

2. 10894033 - Multicyclic compounds and methods of use thereof (2021-01-19),

3. 10562878 - Cycloalkylamines as monoamine reuptake inhibitors (2020-02-18),

4. 10556890 - Heteroaryl compounds and methods of use thereof (2020-02-11),

5. 10428021 - Triple reuptake inhibitors and methods of their use (2019-10-01),

6. 10189825 - Heteroaryl compounds and methods of use thereof (2019-01-29),

7. 10085968 - Multicyclic compounds and methods of use thereof (2018-10-02),

8. 9868718 - Cycloalkylamines as monoamine reuptake inhibitors (2018-01-16),

9. 9850204 - Triple reuptake inhibitors and methods of their use (2017-12-26),

10. 9586888 - Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors (2017-03-07),

11. 9505716 - Pyrrolidine triple reuptake inhibitors (2016-11-29),

12. 9351954 - Multicyclic compounds and methods of use thereof (2016-05-31),

13. 9133117 - Triple reuptake inhibitors and methods of their use (2015-09-15),

14. 9056830 - Pyrrolidine triple reuptake inhibitors (2015-06-16),

15. 8877975 - Cycloalkylamines as monoamine reuptake inhibitors (2014-11-04),

Certainly! Here is an article about the inventor Liming Shao:

Title: A Glimpse into Inventor Liming Shao's Innovations in Neurological Disorders

Introduction:

In the realm of pharmaceuticals and neurological disorders, Inventor Liming Shao has made significant strides in innovation. With a location in Lincoln, MA (US), Liming Shao showcases a remarkable portfolio of 38 patents, focusing on advancements in treating psychosis, schizophrenia, and other neurological conditions.

Latest Patents:

Liming Shao's latest patents include groundbreaking inventions such as "Heteroaryl Compounds and Methods of Use Thereof" and "Multicyclic Compounds and Methods of Use Thereof." These patents introduce novel thiophene and multicyclic compounds, along with methods of synthesis, pharmaceutical compositions, and applications for treating various neurological disorders.

Career Highlights:

Liming Shao's expertise has been instrumental in companies like Sunovion Pharmaceuticals Inc. and Sepracor, Inc., where he has contributed significantly to research and development in the pharmaceutical industry. His innovative approach and dedication have propelled advancements in the treatment and management of neurological disorders.

Collaborations:

Throughout his career, Liming Shao has collaborated with accomplished professionals in the field, including Fengjiang Wang and Brian M. Aquila. Together, they have synergized their expertise to drive forward cutting-edge solutions for addressing complex neurological challenges.

Conclusion:

In conclusion, Liming Shao stands as a pioneering inventor in the realm of pharmaceuticals, particularly in the treatment of neurological disorders. With a rich tapestry of patents and collaborations, his contributions continue to make a profound impact on the healthcare landscape.